Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma
Open Access
- 9 August 2007
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 22 (2) , 441-445
- https://doi.org/10.1038/sj.leu.2404895
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Transcription factor IRF4 controls plasma cell differentiation and class-switch recombinationNature Immunology, 2006
- High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemiaLeukemia, 2004
- Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationBlood, 2000
- A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsBlood, 2000
- MUM1/IRF4 expression as a frequent event in mature lymphoid malignanciesLeukemia, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myelomaNature Genetics, 1997